Evidence on the cost of breast cancer drugs is required for rational decision making

@inproceedings{Berghuis2018EvidenceOT,
  title={Evidence on the cost of breast cancer drugs is required for rational decision making},
  author={Anne Margreet Sofie Berghuis and Hendrik Koffijberg and Leonardus Wendelinus Mathias Marie Terstappen and Stefan Sleijfer and Maarten J. IJzerman},
  booktitle={Ecancermedicalscience},
  year={2018}
}
Background For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology-Magnitude of Clinical benefit Scale, this… CONTINUE READING